Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02749 (
beta2-glycoprotein I
)
836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Outer renal medulla
calmodulin
-binding proteins from a soluble protein fraction and a plasma membrane fraction solubilized in CHAPS were retained on a
calmodulin
-Sepharose 4B column in the presence of Ca2+, and subsequently eluted by EGTA. The
calmodulin
-binding proteins constituted 2.5% of the soluble protein and 0.1% of the solubilized membrane protein.
beta2-glycoprotein I
was identified as a calmodulin-binding protein both by N-terminal sequencing and by immunoblotting. Quantification showed that
beta2-glycoprotein I
constituted the major part (approx. 35%) of the
calmodulin
-binding membrane proteins, but only a minor part (approx. 0.1%) of the
calmodulin
-binding proteins in the soluble fraction. These results show for the first time that
beta2-glycoprotein I
binds
calmodulin
and that
beta2-glycoprotein I
may in kidney be a membrane-associated protein. Immunohistochemical studies identified
beta2-glycoprotein I
in several parts of the cortex and the medulla of the kidney, including Bowman's capsula, the tubular lumen and the tubular epithelium, indicating that
beta2-glycoprotein I
, despite its relatively high molecular mass, is filtrated in the glomerulus and subsequently reabsorbed by the tubular epithelium. This is in agreement with
beta2-glycoprotein I
being a marker for renal tubular disease.
...
PMID:Identification of beta2-glycoprotein I as a membrane-associated protein in kidney: purification by calmodulin affinity chromatography. 918 40
beta2-Glycoprotein I was shown to bind reversibly to
calmodulin
in a Ca2+-dependent manner with a 1:1 stoichiometry, a Kd of 3 x 10(-9) M and a Hill coefficient of 1.4. A sequence in
beta2-glycoprotein I
(Lys-Pro-Gly-Tyr-Val-Ser-Arg-Gly-Gly-Met-Arg-Lys-Phe-Ile-) limited by Cys-32 and Cys-47 is suggested to be the
calmodulin
-binding region. This sequence was the only one in
beta2-glycoprotein I
theoretically having the ability to form a basic amphiphilic alpha-helix typical of a
calmodulin
binding sequence. The peptide corresponding to this sequence was synthesized and found to inhibit the interaction between
beta2-glycoprotein I
and
calmodulin
with an IC50 value of 0.38 x [
beta2-glycoprotein I
] and to displace the
beta2-glycoprotein I
from the
beta2-glycoprotein I
/
calmodulin
complex with an IC50 value of 0.90 x [
beta2-glycoprotein I
].
...
PMID:Characterization of the interaction between beta2-glycoprotein I and calmodulin, and identification of a binding sequence in beta2-glycoprotein I. 918 41